0 Комментарии
0 Поделились
110 Просмотры
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Статьи пользователей
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Congenital Protein C Deficiency Treatment Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Congenital Protein C Deficiency Treatment Market Data Bridge Market Research analyses a growth rate in the congenital protein C deficiency treatment market in the forecast period 2023-2030. The expected CAGR of congenital protein C deficiency treatment market is tend to be around 7% in the mentioned forecast...0 Комментарии 0 Поделились 53 Просмотры
-
Global Scleroderma Therapeutics Market to Reach $3.83 Billion by 2033, Growing at 4.03% CAGRMarket Overview The global scleroderma therapeutics market size was valued at USD 2.66 billion in 2024 and is projected to grow from USD 2.79 billion in 2025 to reach USD 3.83 billion by 2033, exhibiting a CAGR of 4.03% during the forecast period (2025-2033). The global Scleroderma Therapeutics market is witnessing swift transformation driven by new consumer...0 Комментарии 0 Поделились 3Кб Просмотры
-
Lemierre Syndrome Treatment Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Lemierre Syndrome Treatment Market Data Bridge Market Research analyses that the limerre syndrome treatment market which was USD 2.52 billion in 2022, is expected to reach upto USD 5.80 million by 2030, and is expected to undergo a CAGR of 6.2% during the forecast period. Lemierre Syndrome Treatment...0 Комментарии 0 Поделились 102 Просмотры
-
Neurofibromatosis Drugs Market Innovation and Pipeline AnalysisNeurofibromatosis is a rare genetic disorder characterized by the growth of tumors along nerves in the skin, brain, and other parts of the body. The increasing prevalence of rare neurological disorders, advancements in targeted therapies, and rising investments in orphan drug development are driving significant growth in the neurofibromatosis drugs industry. Pharmaceutical companies are...0 Комментарии 0 Поделились 356 Просмотры
-
Spinal Muscular Atrophy (SMA) Treatment Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Spinal Muscular Atrophy (SMA) Treatment Market Data Bridge Market Research analyses that the spinal muscular atrophy (SMA) treatment market, which was USD 4,623.46 million in 2022, would rise to USD 18,718.08 million by 2030 and is expected to undergo a CAGR of 19.10% during the forecast period 2023 to...0 Комментарии 0 Поделились 77 Просмотры
© 2026 Khajiit Nation
Russian